The present invention provides a medicament which results in delivery of a therapeutic level of one or more cannabinoids during a clinically relevant therapeutic window. The therapeutic window is a longer window than provided by an immediate release medicament such as Marinol containing an equivalent amount of the cannabinoid. Oral administration of the present compositions provides therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of treating cannabinoid-sensitive disorders.
申请公布号
WO2011063164(A2)
申请公布日期
2011.05.26
申请号
WO2010US57302
申请日期
2010.11.18
申请人
STEADY SLEEP RX CO., INC.;CARLEY, DAVID;LETENDRE, PETER;FEDDE, KENTON;KOLENG, JOHN
发明人
CARLEY, DAVID;LETENDRE, PETER;FEDDE, KENTON;KOLENG, JOHN